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Filamin C
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Integrin linked kinase pathwayArrhythmogenic cardiomyopathy (ACM) encompasses a group of inherited cardiomyopathies including arrhyth-
mogenic right ventricular cardiomyopathy (ARVC) whose molecular disease mechanism is associated with dys-
regulation of the canonical WNT signalling pathway. Recent evidence indicates that ARVC and ACM caused by
pathogenic variants in the FLNC gene encoding ﬁlamin C, a major cardiac structural protein, may have different
molecular mechanisms of pathogenesis. We sought to identify dysregulated biological pathways in FLNC-
associated ACM.
RNA was extracted from seven parafﬁn-embedded left ventricular tissue samples from deceased ACM patients
carrying FLNC variants and sequenced.
Transcript levels of 623 genes were upregulated and 486 genes were reduced in ACM in comparison to control
samples. The cell adhesion pathway and ILK signalling were among the prominent dysregulated pathways in
ACM. Consistent with these ﬁndings, transcript levels of cell adhesion genes JAM2, NEO1, VCAM1 and PTPRC
were upregulated in ACM samples. Moreover, several actin-associated genes, including FLNC, VCL, PARVB and
MYL7, were suppressed, suggesting dysregulation of the actin cytoskeleton. Analysis of the transcriptome for dys-
regulated biological pathways predicted activation of inﬂammation and apoptosis and suppression of oxidative
phosphorylation and MTORC1 signalling in ACM.
Our data suggests dysregulated cell adhesion and ILK signalling as novel putative pathogenicmechanisms of ACM
caused by FLNC variantswhich are distinct from the postulated diseasemechanismof classic ARVC causedby des-
mosomal genemutations. This knowledge could help in the design of future gene therapy strategieswhichwould
target speciﬁc components of these pathways and potentially lead to novel treatments for ACM.; ARVC, arrhythmogenic right ventricular cardiomyopathy; DEGs, differentially expressed genes; DCM, dilated cardiomyopathy;
ogy; GSEA, gene set enrichment analysis; ILK, integrin linked kinase; IPA, ingenuity pathway analysis; KEGG, Kyoto encyclopedia
nistic target of rapamycin complex 1; SCD, sudden cardiac death.
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Arrhythmogenic cardiomyopathy (ACM) is an important cause of
sudden cardiac death (SCD) in those under 35 years of age [1]. ACM is
characterised by global or regional ventricular dysfunction associated
with ﬁbro-fatty replacement of the myocardium, conduction defects,
and arrhythmias [2].
Arrhythmogenic right ventricular cardiomyopathy (ARVC), a major
subtype of ACM, is considered a disease of the desmosome, commonly
caused by mutations in genes coding for major desmosomal proteins
[2,3]. CanonicalWNT signalling has been implicated in the pathogenesis
of classic ARVC caused bymutations in desmosomal genes [4]. However,
the role of this signalling pathway in other subtypes of ACM is
unknown.
Pathogenic variants in the FLNC gene encoding ﬁlamin C, also
known as actin binding like protein γ-ﬁlamin, a major structural
protein, have been recognised to cause several cardiomyopathies
associated with SCD including ACM [5–8]. We recently studied
the clinical and molecular “signature” of FLNC-associated disease
in pedigrees with ACM as well as in ﬁxed cardiac tissue specimens
from deceased ACM cases with FLNC pathogenic variants [9]. In that
study immunohistochemistry analysis provided early evidence
that the pathogenic mechanism related to genetic variants in
FLNC may be different to typical ARVC [9]. However, currently the
disease mechanisms related to FLNC are mostly unknown as is the
molecular pathogenesis of ACM caused by FLNC variants. The pur-
pose of this study was to gain insights into the molecular patho-
genesis of ACM caused by FLNC variants.2. Methods
2.1. Sample selection
Fixed cardiac tissue from six deceased ACM cases with FLNC var-
iants was obtained through a collaborative research project be-
tween Spanish pathology centres and hospitals as previously
described [9]. All cases were sudden cardiac death victims with a
diagnosis of ARVC or left dominant arrhythmogenic cardiomyopa-
thy at post mortem. [9]. FLNC variants include ﬁve pathogenic and
one variant of unknown signiﬁcance according to the American
College of Medical Genetics (ACMG) variant classiﬁcation [10]. In
addition, one ACM case carrying the novel c.7252-1GNA splicing
variant in FLNC (also classiﬁed as pathogenic) was identiﬁed from
sudden death archive cases in the UK. All cases were negative for
pathogenic variants in other known ACM genes. A list of FLNC var-
iants present in samples used in this study is provided in Appendix
Table A.1.
In total, parafﬁn embedded left ventricular (LV) tissue samples
were available from seven patients for RNA extraction and se-
quencing. Parafﬁn ﬁxed LV samples from four age-matched indi-
viduals, who died from non-cardiac conditions, were used as
controls.
All procedures performed in studies involving human participants
were in accordance with the ethical standards of the relevant NHS
Health Research Authority Ethics Committees (REC ID: 15/LO/0549) in
the UK, CEIC Hospital Virgen de la Arrixaca, − CEIC Hospital
Universitario y Politécnico La Fe in Spain and with the 1964 Helsinki
declaration and its later amendments. Human samples and data on sud-
den death caseswere collectedwith informed consent from ﬁrst-degree
family members.. Sabater-Molina, et al., RNA
ournal of Cardiology, https://d2.2. RNA sequencing
RNA from LV tissue was extracted and sequenced by Qiagen as a
commercial service project. Detailed methodology is provided in the
Appendix (Supplementary methods).
2.3. Pathway analysis
Advanced bioinformatic data analysis and interpretation was com-
pleted in-house usingWebGestalt, g:Proﬁler (g:GOSt) and Qiagen Inge-
nuity Pathway Analysis (IPA) as described in detail in the
Supplementary material, Appendix.
2.4. Quantitative polymerase chain reaction (qPCR)
Comprehensive validation of changes in the transcript levels of the
target genes, detected by RNA-seq, was not feasible due to limited
amount of tissue samples available. Therefore, changes in the transcript
levels of selected genes related to the predicted dysregulated pathways
were investigated by qPCR. In particular, Taqman assays (Thermo Fisher
Scientiﬁc) were used for ﬁve genes: FLNC, Hs00155124_m1; VCL,
Hs00419715_m1; PARVB, Hs00203381_m1; THBS4, Hs00170261_m1;
MYL7, Hs01085598_g1 (Supplementary methods, Appendix Table A.2).
3. Results
3.1. RNA sequencing quality
On average 53.1 million reads were obtained per sample. It is esti-
mated that 40 million reads per sample for total RNA-seq is sufﬁcient
for detecting differential expression of genes [11]. Approximately,
26.4% of the sequence reads were mapped to the reference human ge-
nome assembly GRCh37 (hg19) and were used in subsequent analysis.
3.2. Differentially expressed genes (DEGs)
Analysis of RNA-seq data led to identiﬁcation of 623 upregulated
genes, 486 downregulated genes, 92 upregulated isoforms and 127
downregulated isoforms, all with a q value b0.05, in ACMhearts as com-
pared to controls (Fig. 1A). The DEGs were targets of a number of tran-
scriptional regulators, including STAT1, IRF family of transcription
factors, CEBPB andCTNNB1,whichwere predicted, based on their target
transcript levels, to be among themost activated transcriptional regula-
tors, whereas TRIM24 andMYCN were predicted to be among the most
suppressed transcriptional regulators (Fig. 1B and C).
The DEGs identiﬁed were ﬁltered as shown in Appendix Fig. A.1A
and B to produce a gene list for GeneOntology (GO) terms and pathway
analysis by different software programmes. In accord with the known
interactions of FLNC with the actin cytoskeleton in striated muscles
and its perceived functions in localization of signalling receptors and
the structural organization of Z-discs [12], the most enriched Gene On-
tology terms found by bothWebGestalt and g:GOSt included ‘cell adhe-
sion’ (p = 5.70 × 10−23), ‘extracellular matrix organization’ (p =
4.91 × 10−22) and ‘circulatory system development’ (p =
1.24 × 10−12) (Fig. 2 and Appendix Table A.3). Gene set enrichment
analysis (GSEA) also identiﬁed enrichment of genes involved in cell ad-
hesion among the DEGs (Fig. 1D). Heat map of the dysregulated genes
involved in the cell adhesion pathway is shown in Fig. 1E. Thus, themu-
tant FLNC proteins appear to have an impact on themolecular composi-
tion of the extracellular matrix (ECM) and the proteins involved in cell
adhesion or the regulation of cell adhesion.sequencing-based transcriptome proﬁling of cardiac tissue implicates
oi.org/10.1016/j.ijcard.2019.12.002
Fig. 1. Dysregulated gene expression in ACM cardiac tissue samples carrying FLNC variants. A). Volcano plots showing differentially expressed genes (q b 0.05) in ACM samples compared
to controls. Z score plots showing transcriptional regulators targeting B). upregulated or C). downregulated genes. D). Gene set enrichment analysis plot of differentially expressed genes
showing enrichment of genes involved in cell adhesion. E). Heatmap of dysregulated genes in the cell adhesion pathway.
3C.L. Hall et al. / International Journal of Cardiology xxx (xxxx) xxxWebGestalt was also used to identify themost enriched KEGG path-
ways, as shown in Appendix Table A.4. The most dysregulated KEGG
pathway, which contained FLNC and 23 other dysregulated genes in
the dataset, was the “focal adhesion” pathway (p= 5.67 × 10−5). The
‘protein digestion and absorption’ and ‘ECM-receptor interaction’
KEGG pathways were also dysregulated (p = 6.78 × 10−6 and p =
9.17 × 10−6 respectively).
In the focal adhesion KEGGPathway (https://www.genome.jp/kegg-
bin/show_pathway?map04510 [13] - Appendix Fig. A.2), 18 geneswerePlease cite this article as: C.L. Hall, P. Gurha, M. Sabater-Molina, et al., RNA
novel putative disease mec..., International Journal of Cardiology, https://dupregulated and six genes were downregulated in the cardiac tissue
from FLNC variant carriers compared to control cardiac tissue. The path-
way contains several abbreviations for terms, which group multiple
genes under the same category, including, ECM and GF (growth factor).
To identify enriched pathways within the dataset, after ﬁltering for
signiﬁcance (q b 0.05), genes and isoforms were combined and
uploaded to IPA (Qiagen). This identiﬁed a number of dysregulated
pathways, including those involved in inﬂammation and ILK signalling
among the major dysregulated pathways (Fig. 3A). The correspondingsequencing-based transcriptome proﬁling of cardiac tissue implicates
oi.org/10.1016/j.ijcard.2019.12.002
Fig. 2.Map displaying the most enriched GO terms for the FLNC variant carriers vs control group usingWebGestalt [25]. The enriched GO terms are shown in the context of the ontology
tree; the stronger the red colour in the GO term boxes, the more signiﬁcant the enrichment is. The GO terms in the white boxes are not signiﬁcantly enriched but are included in order to
provide information about the parentage of the enriched terms. gNum, Number of genes in the gene set also in the category. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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map showing the DEGs in the main dysregulated pathways, namely
those involved in inﬂammation and ILK signalling, is shown in Fig. 3C.
The two most signiﬁcantly enriched canonical pathways identiﬁed
by IPA (Appendix Fig. A.3) are the ‘integrin linked kinase pathway’
(ILK pathway, Fig. 4) which contains FLNC (p = 2.17 × 10−5) and the
‘hepatic ﬁbrosis pathway’ (p = 7.75 × 10−7). It is worth noting that
the canonical WNT signalling pathway does not appear to be dysregu-
lated in FLNC cardiac samples.
3.3. Conﬁrmation analysis with qPCR
Changes in the transcript levels of selected DEGs were further vali-
dated byqPCRonRNA extracted from the same parafﬁn cardiac samples
used in the RNA sequencing process. Five genes in the ILK pathway,
FLNC, VCL, PARVB, THBS4 and MYL7, were conﬁrmed to show the same
pattern of dysregulation as found by RNA sequencing at a statistically
signiﬁcant level (p b 0.0001 and p b 0.05) (Appendix Fig. A.5A). In the
cell adhesion pathway, two genes, JAM2, NEO1, showed statistically sig-
niﬁcant increased transcription levels compared to controls (Appendix
Fig. A.5B). Two additional genes, VCAM1 and PTPRC, showed undetect-
able transcript levels in control tissue samples but had detectable tran-
script levels in FLNC cardiac samples (Appendix Fig. A.5B).
4. Discussion
We deﬁned transcriptomic proﬁles in 7 LV samples from patients
with ACM and 4 controls and identiﬁed DEGs in ACM samples associ-
ated with pathogenic variants in the FLNC gene. The notable ﬁndings
were dysregulated pathways pertaining to cell adhesion, extracellular
matrix protein, and inﬂammation. The ﬁndings were replicated across
multiple bioinformatics platforms and were partially validated by
qPCR of selected target genes pertaining to the dysregulated pathways.Please cite this article as: C.L. Hall, P. Gurha, M. Sabater-Molina, et al., RNA
novel putative disease mec..., International Journal of Cardiology, https://dOverall, the most signiﬁcantly enriched pathways were: the focal adhe-
sion pathway, the protein digestion and absorption pathway, and ECM re-
ceptor interaction pathway.
The above three KEGG pathways are intrinsically linked and there is
a great degree of overlap with a large number of genes present in all
three. For example, the protein digestion and absorption pathway and
ECM receptor interaction pathway contain genes that overlap with
those in the focal adhesion pathway but the former did not contain
FLNC. In addition, ECM organization involves proteolysis which links
this pathway to the protein digestion and absorption pathway. Simi-
larly, the ECM receptor interaction pathway is also related to the focal
adhesion pathway, as focal adhesions form a connection between the
actin cytoskeleton of the cell and the extracellular matrix [14]. Given
that the protein digestion and absorption pathways are not cardiac spe-
ciﬁc and the ECM receptor interaction pathway did not directly involve
FLNC, these two pathways were not investigated further.
The IPA software package was used to conﬁrm the KEGG pathway
analysis performed by WebGestalt and identiﬁed the integrin linked ki-
nase (ILK) canonical pathway and the hepatic ﬁbrosis canonical pathway
as most statistically signiﬁcant. The ILK signalling pathway is involved
in the regulation of cell adhesion,migration, differentiation and apopto-
tic cell death [15] and substantially overlaps with the KEGG focal adhe-
sion pathway. In particular, the ILK pathway contains both FLNC and six
other geneswhich are also present in theKEGG focal adhesion pathway:
PARVB, ITGB8, JUN,MAPK10,MYL7 and VCL. The dysregulated hepatic ﬁ-
brosis canonical pathway suggests involvement of genes that are likely
to be commonly involved in the induction of ﬁbrosis in both cardiac and
liver tissue. The hepatic ﬁbrosis pathway, however, did not relate to GO
terms identiﬁed byWebGestalt and g:GOSt and, therefore, was not fur-
ther investigated.
Analysis of the dysregulated genes in the focal adhesion pathway
showed a possible link to the regulation of the actin cytoskeleton.
Focal adhesions form between the actin cytoskeleton and extracellularsequencing-based transcriptome proﬁling of cardiac tissue implicates
oi.org/10.1016/j.ijcard.2019.12.002
Fig. 3. Biological pathways disrupted in ACM cardiac tissue samples carrying FLNC variants identiﬁed by IPA analysis. A). Histogram of dysregulated canonical pathways. B). Heatmap of
DEGs in the ILK pathway. C). Circos plot showing differentially expressed genes in the ILK signalling and inﬂammation pathways.
5C.L. Hall et al. / International Journal of Cardiology xxx (xxxx) xxxmatrix and have the ability to act as signalling transduction platforms
[16]. Actin ﬁlaments are connected to transmembrane receptors of the
integrin family via junctional plaque proteins. In addition, there are a
number of proteins present in the focal adhesion pathway, for example
paxillin, ﬁlamin and vinculin, which interact with the tails of the
integrin subunits either directly or indirectly. These interactions have
both a structural component, linking them to the actin cytoskeleton,
and a role in signal transduction [17].
Comparison of the ILK pathway to the focal adhesion pathway re-
veals important similarities including the presence of FLNC. ILK has
been located in focal adhesions and ﬁbrillar adhesions [18] and is
known to interact with multiple focal adhesion proteins, including
PINCH, alpha-parvin and paxillin [18]. Additionally the proteins in the
ILK pathway are involved in cell adhesion, cytoskeleton organization
and actin reorganization similarly to those in the focal adhesion path-
way (Appendix Fig. A.2 and Fig. 4).
Previous studies have identiﬁed the KEGG focal adhesion and ILK ca-
nonical pathways as vital for cardiac function [19,20]. It is important toPlease cite this article as: C.L. Hall, P. Gurha, M. Sabater-Molina, et al., RNA
novel putative disease mec..., International Journal of Cardiology, https://dhighlight that the dysregulatedpathways in ACMLV samples, annotated
differently in different bioinformatics platforms, all converge to high-
light dysregulated cell adhesion, involved in actin cytoskeleton and
ECM organization, as a mechanism in the pathogenesis of ACM associ-
ated with the FLNC variants. The mechanism seems to differ from
those involved in the pathogenesis of ACM caused by mutations in
genes coding for desmosome proteins.
The focal adhesion pathway also included GSK3b and CTNNB1 genes,
which aremembers of the canonicalWNT signalling pathway. However,
transcript levels of these two genes were unchanged in ACMheart sam-
ples associated with FLNC variants as compared to controls. This is con-
sistent with previous immunohistochemistry analysis which detected
no apparent reduction of the immunoreactive signal for GSK3b in LV
specimens from the same ACM cases [9]. Activation of the ILK/focal ad-
hesion pathways is implicated in activation of β-catenin which, in turn,
binds to the Wnt1 promoter region to upregulate gene transcription
leading to positive feedback of the WNT/β-catenin pathway [21]. Tran-
script levels of the canonical WNT pathway target genes weresequencing-based transcriptome proﬁling of cardiac tissue implicates
oi.org/10.1016/j.ijcard.2019.12.002
Fig. 4. The ILK Signalling pathway generated using IPA. The genes with an outer pink border are present in this dataset. Those coloured in green are downregulated in the FLNC cardiac
specimens and those that are coloured in red/pink are upregulated compared to the control group. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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a consequence of activation of the ILK pathway or independent of it, or
secondary to advanced heart failure, remains unclear. Overall, the ﬁnd-
ing suggests involvement of multiple pathways, particularly those in-
volved in cell adhesion in the pathogenesis of ACM caused by FLNC
variants.
It is also worth noting that the Alpha-parvin/ILK/Pinch1 (PARVA/
ILK/LIMS1) complex, which is involved in linking focal adhesions to
the cytoskeleton, has been previously associatedwith dilated cardiomy-
opathy DCM [22]. Although our dataset shows no dysregulation of this
complex, we did detect a downregulation of Parvin-beta (PARVB), a
paralog of PARVA, in cardiac samples with FLNC variants compared to
control samples. Parvin-beta has been found to localise to focal adhe-
sions as a cytoplasmic adaptor protein playing part in the connection
of integrin receptors to the cytoplasm [23]. Parvin-beta could, therefore,
be having a similar effect on focal adhesion formation as alpha-parvin,
ultimately affecting the structure of the cytoskeleton, and thereby con-
tributing to this unique LV ACM/DCM cross-over phenotype.
Interestingly, a recent study reported an association of novel mis-
sense variants in ILK with arrhythmogenic cardiomyopathy [24]. In
that study, Brodelh et al. presented evidence that in vitro loss of focal ad-
hesion location in mutant cells may be due to disruption of the ILK-
PINCH complex. These ﬁndings are in line with data presented in this
study that suggest a dysregulation of the ILK pathway in ACM cardiac
tissue.
Given the limited quantities of extracted RNA we were able to vali-
date by qPCR changes in transcript levels of a small number of selected
DEGs in the ILK and cell adhesion pathways including actin-associated
genes. We also conﬁrmed suppression of FLNC in LV samples carrying
variants in this gene. This appears to be consistent with recent ﬁndings
that showed reduced immunoreactive signal for ﬁlamin C in the samePlease cite this article as: C.L. Hall, P. Gurha, M. Sabater-Molina, et al., RNA
novel putative disease mec..., International Journal of Cardiology, https://dtissue samples [9]. This data strengthens earlier observations that
ACM caused by FLNC variants is associated with a predominant left ven-
tricle disease pattern [8,9].
4.1. Limitations
This study has a number of limitations including thematerial source
being parafﬁn ﬁxed tissue and the lowyield of intact RNA in such tissues
compared to fresh or frozen cardiac tissues, which hampered extensive
conﬁrmation of the RNA-seq and bioinformatics ﬁndings. The relatively
small quantity of extracted RNA limited qPCR conﬁrmation experiments
to 5 and 4 genes from the focal adhesion and adhesion pathways, re-
spectively. In addition, the small amount of cardiac tissue available pre-
cluded the validation of the results at the protein level by Western
blotting analysis. The study was also limited by the small number of
samples available, in part because of the challenges in collecting
human heart samples and in part because of genetic heterogeneity of
human ACM and uncommon nature of the FLNC variants.
Given that the heart samples were patients with expressed pheno-
types including heart failure, it is difﬁcult to discern the primary
changes resulting directly from FLNC variants from those secondary to
cardiac dysfunction, heart failure, and other cardiac pathologies.
5. Conclusion
This is the ﬁrst study that reports on transcriptomic proﬁles of car-
diac tissue samples from patients with ACM associated with FLNC vari-
ants. The ﬁndings were notable for dysregulated ILK and the focal
adhesion pathways, potentially affecting the actin cytoskeleton organi-
zation and leading to impaired function and dysregulated related sig-
nalling pathways. The ﬁndings implicate disruption to these pathwayssequencing-based transcriptome proﬁling of cardiac tissue implicates
oi.org/10.1016/j.ijcard.2019.12.002
7C.L. Hall et al. / International Journal of Cardiology xxx (xxxx) xxxas putative disease mechanisms in ACM caused by the FLNC variants.
Our data suggests the presence of different pathogenic mechanisms be-
tweenARVC caused bymutant desmosomeproteins, which involves the
canonical WNT signalling pathway, and ACM caused by FLNC variants,
which may involve disruption of cell adhesion pathways. As this is the
ﬁrst study reporting on the transcriptomic proﬁle of FLNC-associated
ACM, these ﬁndings need to be conﬁrmed by future studies which will
focus on the interactions betweenmutant ﬁlamin C and speciﬁc compo-
nents of the identiﬁed pathways.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2019.12.002.
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